Evaluation of the Safety of Cytokine-Induced-Killer Cells During Early Transplant Period of Autologous Hematopoietic Stem Cell Transplant Recipients.

Clinical trial NCT07692607 · COMPLETED

Trial details

NCT number: NCT07692607
Sponsor: LucasBio
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Autologous Hematopoietic Stem Cell Transplant

Start date: 2022-03-28
Primary completion: 2025-02-11
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.